ACTIVITY 11:
A} PURCHASE OF 10,000 KCB SHARES AT AVERAGE PRICE OF KSH 18.75B} TAKING UP OF 111 STANCHART RIGHTS AT OFFER PRICE OF KSH 165.45COST OF ACTIVITY 11:
A} COST OF 10,000 KCB SHARES = KSH 187,500
Add 2% transaction costs = KSH 3,750
Total cost of Transaction =
KSH 191,250B} COST OF TAKING UP 111 SCBK RIGHTS =KSH 18,365
TOTAL COST OF ACTIVITY 11: KSH 209,615
CASH IN HAND AFTER ACTIVITY 10: KSH 462,890
CASH IN HAND AFTER ACTIVITY 11: KSH 253,275
SUMMARY AFTER ACTIVITY 11:SHARES: 10,000 KCB SHARES
2,111 STANCHART SHARES
CASH IN HAND: KSH 253,275
RATIONALE OF ACTIVITY 11:
A)STANCHART:The company will soon be announcing the Q3 results accompanied with an interim dividend. I remain bullish on this share.
SCBK (and BAT(K)) are scheduled for some capital gains and interim dividend payments after the Q3 release of results next month.
B)KCB: At current share price, i find KCB hard to ignore. Currently trading at a trailing P/E of 12.3. The forward EPS for 2010 (I estimate it at Ksh 2 per share)should almost approximate the 2009 EPS of KSH 2.05 despite the additional issued and paid up shares.
(Estimated Net profit for 2010:Ksh 5.9B)
A generous dividend payment of 50-60% of profit is anticipated (KCB rights ensured company has a health capital hence reducing need to withhold too much of profit).
In Feruary-March 2011, when the 2010 results are released (and most of the shares have been mopped up by institutional investors), the KCB share should be trading at a trailing P/E of at least 13 (hence a target price of at least Ksh 26).
I will be strengthening my position in KCB on price dips (below Ksh 19)
(A more detailed analysis of KCB to follow).
Happy hunting.
x handle: @stocksmaster79